ReviewJournal for immunotherapy of cancer2025

Role of high-dose interleukin-2 for melanoma in the age of cellular therapy.

Elizabeth Buchbinder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.